Form 4: NeuroOne Medical Technologies Executive Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Steve Mertens, Chief Technology Officer of NeuroOne Medical Technologies, disposed of 252 shares of common stock on October 31, 2024, to cover tax obligations.
Summary
- On October 31, 2024, Steve Mertens, the Chief Technology Officer of NeuroOne Medical Technologies Corp, disposed of 252 shares of common stock.
- The transaction was executed at a price of $0.97 per share.
- This disposal was related to covering tax obligations.
- Following the transaction, Mertens directly owns 173,085 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: Neutral sentiment as the transaction appears to be routine and related to tax obligations, not necessarily reflecting a change in the executive's view of the company's prospects.
Industry Context
This is a routine transaction related to tax obligations and doesn't necessarily indicate a change in the executive's confidence in the company.
Stakeholder Impact
- The disposal of shares by an executive could have a minor psychological impact on shareholders, but the small number of shares involved suggests it is unlikely to be significant.
Key Dates
| Date | Description |
|---|---|
| 10/31/2024 | Date of the stock disposal transaction. |
| 11/01/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.